Journal of dental hygiene science (치위생과학회지)

The Korean Society of Dental Hygiene Science (한국치위생과학회)
권호 표지
DOI QR코드

DOI QR Code

Effect of Resveratrol on Oral Cancer Cell Invasion Induced by Lysophosphatidic Acid

  • Kim, Jin Young (Department of Pharmacology, College of Medicine, Konyang University) ;
  • Cho, Kyung Hwa (Department of Pharmacology, College of Medicine, Konyang University) ;
  • Lee, Hoi Young (Department of Pharmacology, College of Medicine, Konyang University)
  • Received : 2018.04.30
  • Accepted : 2018.05.26
  • Published : 2018.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

The aim of the current study was to demonstrate the potential therapeutic efficacy of resveratrol in oral cancer patients. Lysophosphatidic acid (LPA) intensifies cancer cell invasion and metastasis, whereas resveratrol, a natural polyphenolic compound, possesses antitumor activity, suppressing cell proliferation and progression in various cancer cell lines (ovarian, gastric, oral, pancreatic, colon, and prostate cancer cells). In addition, resveratrol has been identified as an inhibitor of LPA-induced proteolytic enzyme expression and ovarian cancer invasion. Furthermore, resveratrol was shown to inhibit oral cancer cell invasion by downregulating hypoxia-inducible factor $1{\alpha}$ and vascular endothelial growth factor expression. Recently, we demonstrated that LPA is important for the expression of transcription factors TWIST and SLUG during epithelial-mesenchymal transition (EMT) in oral squamous carcinoma cells. In this study, we treated serum-starved cultures of oral squamous carcinoma cell line YD-10B with resveratrol for 24 hours prior to stimulation with LPA. To identify an optimal resveratrol concentration that does not induce apoptosis in oral squamous carcinoma cells, we determined the toxicity of resveratrol in YD-10B cells by assessing their viability using the MTT assay. Another assay was performed using Matrigel-coated cell culture inserts to detect oral cancer cell invasion activity. Immunoblotting was applied for analyzing protein expression of SLUG, TWIST1, E-cadherin, and GAPDH. We demonstrated that resveratrol efficiently inhibited LPA-induced oral cancer cell EMT and invasion by downregulating SLUG and TWIST1 expression. Therefore, resveratrol may potentially reduce oral squamous carcinoma cell invasion and metastasis in oral cancer patients, improving their survival outcomes. In summary, we identified new targets for the development of therapies against oral cancer progression and characterized the therapeutic potential of resveratrol for the treatment of oral cancer patients.

Keywords

References

  1. Robinson KL, Macfarlane GJ: Oropharyngeal cancer incidence and mortality in Scotland: are rates still increasing? Oral Oncol 39: 31-36, 2003. https://doi.org/10.1016/S1368-8375(02)00014-3
  2. Han JH, Kim EK, Lim SH, Kim CH: Literature review on the incidence and risk factor of oral cancer. J Dent Hyg Sci 12: 451-458, 2012.
  3. Roepman P, Wessels LF, Kettelarij N, et al.: An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet 37: 182-186, 2005. https://doi.org/10.1038/ng1502
  4. Mandal M, Myers JN, Lippman SM, et al.: Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features. Cancer 112: 2088-2100, 2008. https://doi.org/10.1002/cncr.23410
  5. Kopp P: Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'? Eur J Endocrinol 138: 619-620, 1998. https://doi.org/10.1530/eje.0.1380619
  6. Savouret JF, Quesne M: Resveratrol and cancer: a review. Biomed Pharmacother 56: 84-87, 2002. https://doi.org/10.1016/S0753-3322(01)00158-5
  7. Gupta SC, Kannappan R, Reuter S, Kim JH, Aggarwal BB: Chemosensitization of tumors by resveratrol. Ann N Y Acad Sci 1215: 150-160, 2011. https://doi.org/10.1111/j.1749-6632.2010.05852.x
  8. Tyagi A, Singh RP, Agarwal C, Siriwardana S, Sclafani RA, Agarwal R: Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells. Carcinogenesis 26: 1978-1987, 2005. https://doi.org/10.1093/carcin/bgi165
  9. Yang SH, Kim JS, Oh TJ, et al.: Genome-scale analysis of resveratrol-induced gene expression profile in human ovarian cancer cells using a cDNA microarray. Int J Oncol 22: 741-750, 2003. https://doi.org/10.3892/ijo.22.4.741
  10. Kim YN, Choe SR, Cho KH, et al.: Resveratrol suppresses breast cancer cell invasion by inactivating a RhoA/YAP signaling axis. Exp Mol Med 49: e296, 2017. https://doi.org/10.1038/emm.2016.151
  11. Kim SH, Cho KH, Kim YN, et al.: Resveratrol attenuates norepinephrine-induced ovarian cancer invasiveness through downregulating hTERT expression. Arch Pharm Res 39: 240-248, 2016. https://doi.org/10.1007/s12272-015-0666-8
  12. Kim SE, Shin SH, Lee JY, et al.: Resveratrol induces mitochondrial apoptosis and inhibits epithelial-mesenchymal transition in oral squamous cell carcinoma cells. Nutr Cancer 70: 125-135, 2018. https://doi.org/10.1080/01635581.2018.1397708
  13. Chang CH, Lee CY, Lu CC, et al.: Resveratrol-induced autophagy and apoptosis in cisplatin-resistant human oral cancer CAR cells: a key role of AMPK and Akt/mTOR signaling. Int J Oncol 50: 873-882, 2017. https://doi.org/10.3892/ijo.2017.3866
  14. Baek SH, Ko JH, Lee H, et al.: Resveratrol inhibits STAT3 signaling pathway through the induction of SOCS-1: role in apoptosis induction and radiosensitization in head and neck tumor cells. Phytomedicine 23: 566-577, 2016. https://doi.org/10.1016/j.phymed.2016.02.011
  15. Yu XD, Yang JL, Zhangddd, et al.: Resveratrol inhibits oral squamous cell carcinoma through induction of apoptosis and G2/M phase cell cycle arrest. Tumour Biol 37: 2871-2877, 2016. https://doi.org/10.1007/s13277-015-3793-4
  16. Subramanian S, Sankaranarayanan R, Bapat B, et al.: Cost-effectiveness of oral cancer screening: results from a cluster randomized controlled trial in India. Bull World Health Organ 87: 200-206, 2009. https://doi.org/10.2471/BLT.08.053231
  17. Kim HD, Paik DI, Jung SH, Park DY, Kim JB: Factors influencing knowledge about early signs and causes of oral cancer in Korean elder. J Korean Acad Dent Health 28: 570-582, 2004.
  18. Lee EJ, Kim J, Lee SA, et al.: Characterization of newly established oral cancer cell lines derived from six squamous cell carcinoma and two mucoepidermoid carcinoma cells. Exp Mol Med 37: 379-390, 2005. https://doi.org/10.1038/emm.2005.48
  19. Ahrendt SA, Chow JT, Yang SC, et al.: Alcohol consumption and cigarette smoking increase the frequency of p53 mutations in non-small cell lung cancer. Cancer Res 60: 3155-3159, 2000.
  20. Balaram P, Sridhar H, Rajkumar T, et al.: Oral cancer in southern India: the influence of smoking, drinking, paan-chewing and oral hygiene. Int J Cancer 98: 440-445, 2002. https://doi.org/10.1002/ijc.10200
  21. Chen SJ, Liu H, Liao CT, et al.: Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature. Oncotarget 6: 18066-18080, 2015. https://doi.org/10.18632/oncotarget.3768
  22. Tamura T, Ichikawa T, Nakahata S, et al.: Loss of NDRG2 expression confers oral squamous cell carcinoma with enhanced metastatic potential. Cancer Res 77: 2363-2374, 2017. https://doi.org/10.1158/0008-5472.CAN-16-2114
  23. Benesch MG, Ko YM, McMullen TP, Brindley DN: Autotaxin in the crosshairs: taking aim at cancer and other inflammatory conditions. FEBS Lett 588: 2712-2727, 2014. https://doi.org/10.1016/j.febslet.2014.02.009
  24. Brusevold IJ, Tveteraas IH, Aasrum M, Odegard J, Sandnes DL, Christoffersen T: Role of LPAR3, PKC and EGFR in LPA-induced cell migration in oral squamous carcinoma cells. BMC Cancer 14: 432, 2014. https://doi.org/10.1186/1471-2407-14-432
  25. Cho KH: Lysophosphatidic acid-induced TWIST1 and slug expression in oral cancer cell invasion. J Dent Hyg Sci 17: 433-438, 2017. https://doi.org/10.17135/jdhs.2017.17.5.433
  26. Shan Z, Yang G, Xiang W, Pei-jun W, Bin Z: Effects of resveratrol on oral squamous cell carcinoma (OSCC) cells in vitro. J Cancer Res Clin Oncol 140: 371-374, 2014. https://doi.org/10.1007/s00432-013-1575-1
  27. Zhang Q, Tang X, Lu QY, Zhang ZF, Brown J, Le AD: Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells. Mol Cancer Ther 4: 1465-1474, 2005. https://doi.org/10.1158/1535-7163.MCT-05-0198

Cited by

  1. Effect of STAT3 on Lysophosphatidic Acid-Induced Oral Cancer Cell Invasion vol.19, pp.2, 2018, https://doi.org/10.17135/jdhs.2019.19.2.141
  2. Therapeutic applications of herbal/synthetic/bio-drug in oral cancer: An update vol.890, pp.None, 2018, https://doi.org/10.1016/j.ejphar.2020.173657
  3. Plant-Based Antioxidant Extracts and Compounds in the Management of Oral Cancer vol.10, pp.9, 2018, https://doi.org/10.3390/antiox10091358